Rchr
J-GLOBAL ID：201701006441572300
Update date: Feb. 01, 2024
Shimamori Yuzuki
Shimamori Yuzuki
Research field (1)：
Bacteriology
Research keywords (2)：
bacteriophage
, Phage therapy
Research theme for competitive and other funds (2)：
- 2022 - 2025 ファージ製剤の腸管内へのデリバリーシステムの構築
- 2019 - 2022 Mycobacteriophage therapy for non-tuberculous mycobacterial diseases
Papers (3)：
-
Yuzuki Shimamori, Ajeng K Pramono, Tomoe Kitao, Tohru Suzuki, Shin-Ichi Aizawa, Tomoko Kubori, Hiroki Nagai, Shigeki Takeda, Hiroki Ando. Isolation and Characterization of a Novel Phage SaGU1 that Infects Staphylococcus aureus Clinical Isolates from Patients with Atopic Dermatitis. Current microbiology. 2021. 78. 4. 1267-1276
-
Yuzuki Shimamori, Shoichi Mitsunaka, Hirotaka Yamashita, Tohru Suzuki, Tomoe Kitao, Tomoko Kubori, Hiroki Nagai, Shigeki Takeda, Hiroki Ando. Staphylococcal Phage in Combination with Staphylococcus Epidermidis as a Potential Treatment for Staphylococcus Aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants. Viruses. 2020. 13. 1
-
Nao Tsukamoto, Yuko Kanazawa, Yuzuki Shimamori, Keiko Yoshida, Shigeki Takeda. Identification of a morphogenic intermediate of the bacteriophage Mu Baseplate. Advances in Microbiology. 2014. 4. 1155-1163
MISC (2)：
-
島守 祐月, 大原 直也, 露口 一成, 大屋 賢司, 吉田 志緒美, 武田 茂樹, 永井 宏樹, 安藤 弘樹. マイコファージによる非結核性抗酸菌症の予防法と治療法の確立. 日本細菌学雑誌. 2019. 74. 1. 51-51
-
島守 祐月, 大原 直也, 露口 一成, 大屋 賢司, 吉田 志緒美, 武田 茂樹, 永井 宏樹, 安藤 弘樹. マイコファージによる非結核性抗酸菌症の予防法と治療法の確立. 日本細菌学雑誌. 2019. 74. 1. 51-51
Professional career (1)：
- science and technology (Gunma University)
Return to Previous Page
